ScripWho: Johnson & Johnson/Pipeline Therapeutics What: J&J obtains worldwide licensing rights to Pipeline’s PIPE-307, a Phase I candidate ready to move into Phase II in relapsing/remitting multiple scl
ScripRed Tree Venture Capital hopes to provide early-stage VC funding to life science start-ups emerging from academic and research institutions on the West Coast – funding that, the firm believes, has bee
ScripHalfway through February, seven different sources of funding for health care and life science innovations have announced newly raised pools of cash totaling $2.2bn for a wide array of technologies, in